Home
News
Videos
Podcasts
Slides
Visual Abstracts
Topics
Conferences
- SCAI 2018
- ACC 2018
- AHA 2017
- ESC 2017
- SCAI 2017
- ACC 2017

COAPT: A Randomized Trial of Transcatheter Mitral Valve Leaflet Approximation in Patients With Heart Failure and Secondary Mitral Regurgitation

By Ahmed Younes, M.D. on September 27, 2018

Download (PPTX, 3.24MB)

t f

Post-Hoc Analysis of DAPA-HF: Dapagliflozin Use Is Associated With Rapid Reduction of Cardiovascular Death Among Patients With Heart Failure With Reduced Ejection Fraction

A recent study by Dr. David D. Berg, published in JAMA Cardiology, found that the… Continue Reading

By Sahar Memar Montazerin, MD
February 22, 2021

Early Atrial Fibrillation Clinical Trial: Superiority of Catheter Cryoablation Over Antiarrhythmic Therapy as First Line Therapy for Paroxysmal Atrial Fibrillation

A recent study by Dr. Jason G. Andrade, published in New England Journal of Medicine, found… Continue Reading

By Sara Zand, M.D.
January 31, 2021

TIPS-3 Trial: The Combination of Polypill and Aspirin Administered to Patients at Intermediate Risk Led to a Lower Incidence of Cardiovascular Events Compared With Double Placebo

A recent trial by Dr. Salim Yusuf, published in The New England Journal of Medicine, indicated… Continue Reading

By Sahar Memar Montazerin, MD
January 25, 2021

Create an Account

CLICK TO REGISTER

Cardiology Now News is sponsored by the Baim Institute for Clinical Research and produced by the PERFUSE Study Group. Baim and PERFUSE are academic research organizations led by world class cardiovascular clinical trialists and opinion leaders.

Receive the latest news, interviews, podcasts directly to your inbox

Leave a Reply Cancel reply

More from Clinical Trials

Post-Hoc Analysis of DAPA-HF: Dapagliflozin Use Is Associated With Rapid Reduction of Cardiovascular Death Among Patients With Heart Failure With Reduced Ejection Fraction

Early Atrial Fibrillation Clinical Trial: Superiority of Catheter Cryoablation Over Antiarrhythmic Therapy as First Line Therapy for Paroxysmal Atrial Fibrillation

TIPS-3 Trial: The Combination of Polypill and Aspirin Administered to Patients at Intermediate Risk Led to a Lower Incidence of Cardiovascular Events Compared With Double Placebo